Treatment for aberrant behavior in persons diagnosed with developmental disabilities typically involves either behavioral interventions or medication. Often, the treatment is a combination of the two. Schroeder and coworkers Adv Learn Behav Disabil 2:179-225) outlined criteria for the evaluation of
Risks for severe mental retardation occurring in isolation and with other developmental disabilities
β Scribed by Laura L. Jelliffe-Pawlowski; Gary M. Shaw; Verne Nelson; John A. Harris
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 64 KB
- Volume
- 136A
- Category
- Article
- ISSN
- 1552-4825
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Nutritional, dietary, and hormonal approaches to producing behavioral, emotional, and cognitive changes in individuals with mental retardation and developmental disabilities (MRDD) flourished in the 1970s and 1980s. Although an occasional article is still published, there was little serious research
To various degrees, psychopharmacologic medications are associated with side effects. Despite improvements in newer psychopharmacologic medication, monitoring for side effects remains important for individuals with mental retardation and developmental disabilities for a number of reasons, of which p
Hepatitis B virus (HBV) surface antigen (HBsAg) and antibody to HBsAg (antiHBs) are excellent markers for HBV infection and its immunity. A total of 414 patients, 312 Down syndrome and 102 non-Down's syndrome, were studied, and 142 were residents of an institution (RI), whereas 272 were in nonreside
## Abstract Isolated hemihyperplasia (IH) refers to a distinct diagnosis involving asymmetric overgrowth of single or multiple organs or regions of the body and can result from various genomic changes including molecular alterations of 11p15; these are paternal uniparental disomy (UPD), and alterat